A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Investors interested in arranging a meeting with the Company's management during the conference can register on the BIO CEO & Investor Conference website here.

President Donald Trump has kicked off his second term with a flurry of executive actions on immigration, the economy, DEI and more. In his first trip since becoming president, Trump on Friday heads to ...

The Biden administration - in its final weeks - quietly stacked a key health committee in a move that could sabotage Robert F ...

At today's confirmation hearing, Democratic senators were skeptical of the HHS Secretary nominee Robert F. Kennedy Jr.'s ...